This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday – Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• BTIG analyst Thomas Shrader initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $27. Alto Neuroscience shares closed at $12.11 on Friday. See how other analysts view this stock.
• B of A Securities analyst Travis Steed initiated coverage on Masimo Corporation (NASDAQ:MASI) with a Neutral rating and announced a price target of $162. Masimo shares closed at $151.12 on Friday. See how other analysts view this stock.
• Leerink Partners analyst Marc Goodman initiated coverage on Ovid Therapeutics Inc. (NASDAQ:OVID) with an Outperform rating and announced a price target of $5. Ovid Therapeutics shares closed at $1.3050 on Friday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Yi Chen initiated coverage on Vivos Therapeutics, Inc. (NASDAQ:VVOS) with a Buy rating and announced a price target of $7. Vivos Therapeutics closed at $2.34 on Friday. See how other analysts view this stock.
• Benchmark initiated coverage on TAT Technologies Ltd. (NASDAQ:TATT) with a Buy rating and announced a price target of $53. TAT Technologies shares closed at $40.04 on Friday. See how other analysts view this stock.

Considering buying ANRO stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Warns ‘The Business Is Really Bad’ At This Consumer Cyclical Stock

Photo via Shutterstock